Navigation Links
Human umbilical cord blood cells found to enhance survival and maturation of key brain cells
Date:12/14/2010

Laboratory culture (in vitro) studies examining the activity of human umbilical cord blood cells (HUCB) on experimental models of central nervous system aging, injury and disease, have shown that HUCBs provide a 'trophic effect' (nutritional effect) that enhances survival and maturation of hippocampal neurons harvested from both young and old laboratory animals.

"As we age, cognitive function tends to decline," said Alison E. Willing, PhD, a professor in the University of South Florida's (USF) Department of Neurosurgery and Brain repair and lead author for a study published in the current issue of Aging and Disease (www.aginganddisease.org) . "Changes in cognitive function are accompanied by changes in the hippocampus, an area of the brain where long term memory, as well as other functions, are located, an area of the brain among those first to suffer the effects of diseases such as Alzheimer's disease."

According to Dr. Willing and her USF co-authors, these changes contribute to stroke and dementia in the aging population when neural cells become more susceptible to stressors and disease processes. Because HUCB cells have received attention as an alternative source of stem cells that have been studied and shown to be effective with wide therapeutic potentials, how the cells might be used to repair the diseased, as well as normally aging brain, has become an important question.

"It is important to understand how these cells may be manipulated to support hippocampal function in order to develop new therapies," she explained. "Accordingly, this study sought to examine the potential for HUCBs to enhance proliferation and increase survival of hippocampal cells derived from aging adult rat brains."

The study found that HUCBs were not only able to protect hippocampal neurons taken from the brains of young adult and aged rats, but also promoted the growth of dendrites - the branching neurons acting as signaling nerve communication channels - as well as induced the proliferation hippocampal neurons.

"These protective effects may be a function of growth factors and cytokines (a small signaling protein linked to the inflammatory response) produced by the HUCB cells," observed Dr. Willing.

The researchers also reported that the difference between HUCB-treated cultures and non-treated cultures was "more dramatic in the older adult rat brain cultures" than in those younger rats. Further, they speculated that synapses - the communication links between neuronal cells -may have been forming in the cultures.

They concluded that HUCB cells benefit aging adult hippocampal neurons by 'increasing their survival, growth, differentiation, maturation and arborization' (branching).

"The mechanisms by which HUCB cells extend the life of hippocampal cells may include enhancing the proliferative capacity of the cells or protecting existing and newly generated neurons from damage and death," concluded Dr. Willing.

According to Dr. John Sladek, professor of neurology at the University of Colorado School of Medicine, this study is important for its potential contribution to regenerative medicine's future ability to benefit from an important source for stem cells, the umbilical cord.

"The fact that HUCBs enhanced the survival of - and maturation of - hippocampal neurons has profound implications for the treating brain injury and degenerative diseases such as Alzheimer's disease, ALS and Parkinson's disease," said Dr. Sladek.


'/>"/>

Contact: Randolph Fillmore
rfillmor@health.usf.edu
813-974-0868
University of South Florida (USF Health)
Source:Eurekalert

Related medicine news :

1. Cognitively-impaired human research subjects need better protection
2. Species Extinctions May Spell Trouble for Human Health
3. Experts urge US to create emergency cholera vaccine stockpile for humanitarian use
4. Female fish -- and humans? -- lose interest when their male loses a slugfest
5. To be or not to be? Public event examines question of human identity and consciousness
6. PARP inhibitor, MK-4827, shows anti-tumor activity in first trial in humans
7. HFES announces Release of Reviews of Human Factors and Ergonomics, Volume 6
8. Rogue gene hijacks stem cells to jumpstart human cancer
9. Scientists Use Tarantulas to Explore Human Fear
10. Dangerous chemicals in food wrappers likely migrating to humans: U of T study
11. Early Humans More Advanced Than Thought
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... ... “Letters From Home”: a moving compilation of letters that remind readers of ... Home” is the creation of published author, John Allred, a passionate leader of ministry ... International, who has traveled and ministered on four continents. , “It is my hope ...
(Date:9/21/2017)... CA (PRWEB) , ... September 21, 2017 , ... With ... so fun and easy to do. Users can select from up to two layers ... with a click of a mouse all within Final Cut Pro X. ...
(Date:9/21/2017)... ... September 21, 2017 , ... The American Addiction Treatment ... for professionals in the addiction treatment industry entitled: Special Investigations Unit (SIU) ... companies and state and federal governments are increasingly scrutinizing the addiction treatment industry ...
(Date:9/21/2017)... ... ... Bill Howe Plumbing’s mission is to create an employee friendly company, provide ... over 37 years, they have operated with their mission at the foundation and have ... They were chosen as the Best San Diego plumber in 2016, named a Top ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... developing low-cost and highly accurate cancer screening tests, has received two prestigious recognitions ... in cancer survival rates. , Preora has been named a Top ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and ... primary and secondary endpoint data for lasmiditan, an investigational, ... which demonstrated statistically significant improvements compared to placebo in ... highlighted today at the 18th Congress of the International ... "The data presented today demonstrate lasmiditan,s potential ...
(Date:9/7/2017)... WARSAW, Ind. , Sept. 7, 2017  Zimmer ... leader in musculoskeletal healthcare, today announced that it will ... Annual Global Healthcare Conference at the Grand Hyatt hotel ... September 11, 2017 at 11:40 a.m. Eastern Time. ... accessed via Zimmer Biomet,s Investor Relations website at ...
Breaking Medicine Technology: